DFTX Earnings Definium Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.71 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -2.06 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | -1.56 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.81 | 2025-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.35 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -1.54 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -1.12 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.01 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.14 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -2.44 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | -1.85 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.41 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.65 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -1.84 | 2024-02-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.82 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.26 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.66 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -3.40 | 2023-03-09 | 10-K |
| Q3 2022 | 2021-09-30 | -2.81 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.15 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.